Related Experiment Video
Updated: Apr 19, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
Non-genetic engineering of cells for drug delivery and cell-based therapy
Qun Wang1, Hao Cheng2, Haisheng Peng3
1Department of Chemical and Biological Engineering, Iowa State University, Ames, IA 50011, USA; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA.
Abstract:
Cell-based therapy is a promising modality to address many unmet medical needs. In addition to genetic engineering, material-based, biochemical, and physical science-based approaches have emerged as novel approaches to modify cells. Non-genetic engineering of cells has been applied in delivering therapeutics to tissues, homing of cells to the bone marrow or inflammatory tissues, cancer imaging, immunotherapy, and remotely controlling cellular functions. This new strategy has unique advantages in disease therapy and is complementary to existing gene-based cell engineering approaches. A better understanding of cellular systems and different engineering methods will allow us to better exploit engineered cells in biomedicine. Here, we review non-genetic cell engineering techniques and applications of engineered cells, discuss the pros and cons of different methods, and provide our perspectives on future research directions.
Related Concept Videos
What is Genetic Engineering?
Gene Therapy
Modified-Release Drug Delivery Systems: Site-Targeted
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against...
Site-Targeted Drug Delivery Systems: Polymeric Carriers

